"Although fragmented at day 1, mitochondria appear hyperfused at day 3 (Figure 4A) [when treated with NR or AZD2281], which, at this time, is now associated with increased gene expression of fzo-1 and opa-1 (Figure 4B)."
"CED-9 interacts with the middle domain of DRP-1."; "Mutations in the BH1 and the BH2 domain of CED-9 affect the ability of CED-9 to interact with DRP-1."; "EGL-1 and GTP enhance the interaction between CED-9 and DRP-1 in vitro."; "CED-4 does not affect GST::DRP-1-CED-9 interaction in vitro."